Latest Antimicrobial Agents and Chemotherapy Stories

2010-09-14 06:20:00

A new "superbug" from India that is resistant to every known antibiotic has sickened people in three states as it continues to spread throughout the globe, health officials said Monday. The bacteria now poses a worldwide threat, warned experts attending the 50th annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), the world's largest gathering of infectious disease specialists. "There is an urgent need, first, to put in place an international...

2009-09-14 14:04:41

Oil-and-water-based nanoemulsion could be more effective than commonly used lotions Treating second-degree burns with a nanoemulsion lotion sharply curbs bacterial growth and reduces inflammation that otherwise can jeopardize recovery, University of Michigan scientists have shown in initial laboratory studies. U-M burn surgeon Mark R. Hemmila, M.D., reports today at the Interscience Conference for Antimicrobial Agents and Chemotherapy on results achieved with a nanoemulsion developed at U-M...

2009-09-14 11:20:00

Researchers reported on Sunday a new experimental flu drug that can stop the swine flu virus from infecting cells and it even seems capable of keeping it from mutating into drug-resistant forms. After performing tests on mice and in lab dishes, they saw that NexBio Inc.'s drug Fludase can stop the seasonal influenza virus from infecting cells while fighting certain strains of the virus that have become resistant to Roche AG's popular influenza drug Tamiflu, the company said. "Extensive,...

2009-09-14 07:00:00

SAN FRANCISCO, Sept. 14 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported long-term data with vicriviroc, its investigational CCR5 receptor antagonist, from an ongoing, open-label extension of the Phase II VICTOR-E1 study in treatment-experienced HIV-infected patients. The results showed that vicriviroc plus optimized background therapy achieved durable virologic suppression and increased CD4 cell counts, and was generally well tolerated over two years of...

2009-09-13 08:19:15

Mayo Clinic researchers say that "teachable software" designed to mimic the human brain may help them diagnose cardiac infections without an invasive exam. Those findings are being presented yesterday at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. Endocarditis -- an infection involving the valves and sometimes chambers of the heart -- can be a problem in patients with implanted medical devices. It is serious and can be deadly. The mortality...

2009-02-04 15:20:00

Ultra-fine oil-and-water emulsion may succeed where antibiotics fail, lab tests suggest University of Michigan scientists report highly encouraging evidence that a super-fine oil-and-water emulsion, already shown to kill many other microbes, may be able to quell the ravaging, often drug-resistant infections that cause nearly all cystic fibrosis deaths. Cystic fibrosis is an inherited chronic lung disease that affects 30,000 children and adults in the United States. Patients have mucus-clogged...

2008-10-26 12:00:11

WASHINGTON, Oct. 26 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today reported a data analysis showing that vicriviroc, its investigational CCR5 receptor antagonist, demonstrated sustained viral suppression and increased CD4 cell counts and was well tolerated through up to four years of therapy in treatment-experienced HIV-infected patients. Vicriviroc was administered once-daily as a single tablet in combination with an optimized antiretroviral regimen containing a...

2005-11-17 14:22:55

By David Douglas NEW YORK (Reuters Health) - Once-daily use of a new extended release (ER) formulation of the antibiotic ciprofloxacin is as effective as twice-daily intermediate-release (IR) ciprofloxacin in clearing up urinary infection in women, according to researchers. Ciprofloxacin ER (brand name Proquin XR, made by Depomed) "showed efficacy that was clearly at least as good as ciprofloxacin IR twice daily," investigator Dr. Bret Berner told Reuters Health. Dr. Berner, of...

Word of the Day
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'